New frontiers in cancer chemotherapy: cis-platinum
Sulkes, A.; Peretz, T.; Rizel, S.; Yahalom, Y.; Brian, S.
Harefuah 110(2): 90-93
1986
ISSN/ISBN: 0017-7768 PMID: 3516805 Document Number: 279032
Document emailed within 1 workday
Related Documents
Hong, R.; Ma, F.; Shi, X.; Li, Q.; Zhang, P.; Yuan, P.; Wang, J.; Fan, Y.; Cai, R.; Li, Q.; Xu, B. 2014: Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs Zhonghua Zhong Liu Za Zhi 36(10): 788-792Maneechawakajorn, J.; Suksuperm, J. 2014: Quality of life in advanced non-small cell lung cancer receiving chemotherapy of platinum combination in old versus new standard chemotherapy regimen Journal of the Medical Association of Thailand 97(Suppl 11): S69-S75
Van Zandwijk, N.; Dalesio, O. 1994: Platinum-based chemotherapy in non-small cell lung cancer: the experience of the European Organization for the Research and Treatment of Cancer Seminars in Oncology 21(3 Suppl 6: 66-71
Forastiere, A.A. 1994: Overview of platinum chemotherapy in head and neck cancer Seminars in Oncology 21(5 Suppl 12: 20-27
Yasui, Y.; Suzumori, K.; Asai, H.; Yagami, Y. 1985: Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer Gan no Rinsho. Japan Journal of Cancer Clinics 31(11): 1415-1421
Bliumenberg, A.G.; Gorbacheva, L.B.; Gorbunova, V.A.; Kozachenko, V.P.; Lankin, V.Z. 1996: Factors of resistance of ovarian cancer to combined chemotherapy with the use of platinum derivatives Biulleten' Eksperimental'noi Biologii i Meditsiny 122(12): 651-654
Welch, R.S.; James, R.D.; Wilkinson, P.M.; Belli, F.; Cowan, R.A. 1995: Recombinant human erythropoietin and platinum-based chemotherapy in advanced ovarian cancer Cancer Journal from Scientific American 1(4): 261-266
Ito, Y.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Imajou, K.; Ozeki, H.; Nagamine, D.; Shinagawa, K. 1987: Combination chemotherapy with cis-platinum, vinblastine and adriamycin for non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(12): 3295-3300
Ishiura, Y.; Yamamoto, H.; Terasaki, Y.; Ishida, Y.; Tohge, M.; Segawa, M.; Kusajima, Y.; Saitoh, K.; Ishikawa, M.; Hirokami, N.; Kasahara, K.; Fujimura, M. 2011: Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 38(13): 2631-2633
Matoda, M.; Omatsu, K.; Yamamoto, A.; Nomura, H.; Tanigawa, T.; Kawamata, Y.; Kato, K.; Umayahara, K.; Takeshima, N. 2014: Importance of platinum-free interval in second-line chemotherapy for advanced or recurrent endometrial cancer European Journal of Gynaecological Oncology 35(3): 224-229
Kucukzeybek, Y.; Gorumlu, G.; Karaca, B.; Erten, C.; Cengiz, E.; Kemal Gul, M.; Karabulut, B.; Uslu, R.; Sanli, U.A.; Goker, E. 2008: Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer Journal of Buon: Official Journal of the Balkan Union of Oncology 13(2): 199-203
Neubauer, H.; Stefanova, M.; Solomayer, E.; Meisner, C.; Zwirner, M.; Wallwiener, D.; Fehm, T. 2008: Predicting resistance to platinum-containing chemotherapy with the ATP tumor chemosensitivity assay in primary ovarian cancer Anticancer Research 28(2a): 949-955
Yuan, P.; Miao, X-ping.; Zhang, X-mei.; Wang, Z-hua.; Tan, W.; Zhang, X-ru.; Sun, Y.; Xu, B-he.; Lin, D-xin. 2006: Association of the responsiveness of advanced non-small cell lung cancer to platinum-based chemotherapy with p53 and p73 polymorphisms Zhonghua Zhong Liu Za Zhi 28(2): 107-110
Bunn, P.A. 1999: Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer Seminars in Oncology 26(1 Suppl 4: 25-30
Katsumata, K.; Yamamoto, K.; Ashizawa, T.; Sumi, T.; Yamashita, S.; Nagashima, K.; Murohashi, T.; Majima, T.; Mori, M.; Takahashi, S.; Koyanagi, Y. 2000: Two cases of recurrent gastric cancer for which combination chemotherapy with pirarubicin, cis-platinum and 5-fluorouracil were markedly effective Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(1): 113-116
Vogl, S.E.; Pagano, M.; Kaplan, B.H.; Einhorn, N.; Arseneau, J.; Moukhtar, M.; Greenwald, E. 1980: Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy Obstetrics and Gynecology 56(5): 635-640
Scarfone, G.; Villa, A.; Parazzini, F.; Sciatta, C.; Polverino, G.; Bolis, G. 1999: A phase I-II trial of high-dose ifosfamide in patients with ovarian cancer refractory or resistant to platinum and/or paclitaxel-containing chemotherapy Tumori 85(4): 217-219
Tanaka, H.; Umekawa, T.; Nagao, K.; Ishihara, A.; Toyoda, N. 2003: Salvage chemotherapy with a combination of irinotecan hydrochloride and mitomycin C in platinum- and paclitaxel-resistant epithelial ovarian cancer: case reports European Journal of Gynaecological Oncology 24(3-4): 337-340
Mori, A.; Hirose, T.; Tamura, A.; Kusaka, K.; Matsui, H.; Ohta, K. 2016: Evaluation of the Efficacy and Safety of Platinum Doublet Re-Challenge Chemotherapy in Patients with Recurrent Advanced Non-Small Cell Lung Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(6): 723-726
Ota, K.; Oguma, T.; Shimamura, K. 1994: Pharmacokinetics of platinum in cancer patients following intravenous infusion of cis-diammine(glycolato)platinum, 254-S Anticancer Research 14(3b): 1383-1387